6 years ago

fool.com.au

Top brokers name 3 ASX shares to buy today

6 years ago

kalkinemedia.com

Phoslock Reaffirms the Revenue Guidance at $27-$30 Million for FY2019

6 years ago

kalkinemedia.com

Sigma Healthcare Limited Reports its 1H20 Performance

6 years ago

proactiveinvestors.com.au

Blackstone Minerals assays show more broad, shallow, high-grade nickel

6 years ago

stockhead.com.au

Hot Chili unveils spicy 596m-long copper-gold hit at Cortadera

6 years ago

mfam.com.au

EML Payments (ASX EML) is a High Growth Global Leader in Alternative Electronic Payment Solutions

6 years ago

smallcaps.com.au

Neuren Pharma granted orphan drug status for treatment of Phelan-McDermid, Pitt Hopkins and Angelman syndromes

6 years ago

proactiveinvestors.com.au

King River Resources recommences drilling at Mt Remarkable Project

6 years ago

kalkinemedia.com

US FDA Granted Orphan Drug Designation to Neuren’s NNZ-2591 drug

6 years ago

kalkinemedia.com

Vast Market Opportunity Awaits K2fly’s SaaS-based Solutions: Infoscope and RCubed